title: Safety of denosumab in giant-cell tumour of bone.
authors.forename: David
authors.initials: D
authors.lastname: Thomas
authors.forename: Phillipe
authors.initials: P
authors.lastname: Carriere
authors.forename: Ira
authors.initials: I
authors.lastname: Jacobs
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D000069448:Denosumab; D018212:Giant Cell Tumor of Bone / Q000188:drug therapy*; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced; D010020:Osteonecrosis / Q000139:chemically induced; D053245:RANK Ligand / Q000009:adverse effects*; D012449:Safety
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D053245:RANK Ligand; D000069448:Denosumab